Cowealth Medical China Co.Ltd. (603122) — Cash Flow Reinvestment Rate
Cowealth Medical China Co.Ltd. (603122) has a Cash Flow Reinvestment Rate of 8.06x as of December 2025, reinvesting CN¥142.58 Million (capex CN¥14.21 Million plus investments CN¥-128.37 Million) from operating cash flow of CN¥17.68 Million. Explore reinvestment intensity of Cowealth Medical China Co.Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cowealth Medical China Co.Ltd. Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Cowealth Medical China Co.Ltd. across 5 annual periods. Also explore Cowealth Medical China Co.Ltd. balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cowealth Medical China Co.Ltd. (2020–2025)
Year-by-year capital reinvestment analysis for Cowealth Medical China Co.Ltd.. For live market cap and broader valuation context, see 603122 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.06x | CN¥142.58 Million | CN¥17.68 Million | CN¥14.21 Million | ▲ +1663.2% |
| 2024 | 0.46x | CN¥60.72 Million | CN¥132.75 Million | CN¥31.82 Million | ▼ -93.5% |
| 2023 | 7.02x | CN¥79.21 Million | CN¥11.28 Million | CN¥67.96 Million | ▲ +24.5% |
| 2021 | 5.64x | CN¥39.55 Million | CN¥7.01 Million | CN¥22.12 Million | ▲ +181.0% |
| 2020 | 2.01x | CN¥148.85 Million | CN¥74.15 Million | CN¥8.11 Million | — |